Results

Johnson & Johnson

05/24/2022 | Press release | Distributed by Public on 05/25/2022 07:38

Janssen Presents Study Results Showing Clinical Efficacy for TREMFYA® (guselkumab) and Long-Term Safety for STELARA® (ustekinumab) for Patients Living with Inflammatory Bowel[...]